$26MSeries A, 28 May 2026
Oversubscribed round led by ARCH funds clinical product development and global commercialization of Countable PCR.
- Amount
- $26M
- Stage
- Series A
- Announced
- 28 May 2026
- Lead
- ARCH Venture Partners
- Other investors
- F-Prime Capital, Primer Ventures
- Use of funds
- Oversubscribed round led by ARCH funds clinical product development and global commercialization of Countable PCR.
- Checked
- Announced by the company
- Sources
- Countable Labs raises $26M for single-molecule PCR businesswire.com
Countable Labs raises $26M for single-molecule PCR ventureburn.com